Evidence map›Paper›PMID 29770331›Full record

ArticleBioMed research international2018

K M Santos, I N F Gomes, R J Silva-Oliveira, F E Pinto, B G Oliveira, R C R Chagas, W Romão, R M V Reis, R I M A Ribeiro

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

K M SantosLaboratory of Experimental Pathology, Federal University of São João del-Rei (UFSJ), West Center Campus Dona Lindu, 35.501-296 Divinópolis, MG, Brazil.
I N F GomesLaboratory of Experimental Pathology, Federal University of São João del-Rei (UFSJ), West Center Campus Dona Lindu, 35.501-296 Divinópolis, MG, Brazil.ORCID 0000-0003-0551-138X
R J Silva-OliveiraMolecular Oncology Research Center (CPOM), Barretos Cancer Hospital, 14.784-400 Barretos, SP, Brazil.
F E PintoPetroleomic and Forensic Chemistry Laboratory, Department of Chemistry, Federal University of Espírito Santo (UFES), 29075-910 Vitória, ES, Brazil.
B G OliveiraPetroleomic and Forensic Chemistry Laboratory, Department of Chemistry, Federal University of Espírito Santo (UFES), 29075-910 Vitória, ES, Brazil.
R C R ChagasAnalytical Chemistry Laboratory, Federal University of São João del-Rei (UFSJ), West Center Campus Dona Lindu, 35.501-296 Divinópolis, MG, Brazil.
W RomãoPetroleomic and Forensic Chemistry Laboratory, Department of Chemistry, Federal University of Espírito Santo (UFES), 29075-910 Vitória, ES, Brazil.
R M V ReisMolecular Oncology Research Center (CPOM), Barretos Cancer Hospital, 14.784-400 Barretos, SP, Brazil.
R I M A RibeiroLaboratory of Experimental Pathology, Federal University of São João del-Rei (UFSJ), West Center Campus Dona Lindu, 35.501-296 Divinópolis, MG, Brazil.ORCID 0000-0002-7374-4743
Federal University of São João del-Rei · BRUniversidade Federal do Espírito Santo · BRHospital de Câncer de Barretos · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastasis remains the most common cause of death in cancer patients. Inhibition of metalloproteinases (MMPs) is an interesting approach to cancer therapy because of their role in the degradation of extracellular matrix (ECM), cell-cell, and cell-ECM interactions, modulating key events in cell migration and invasion. Herein, we show the cytotoxic and antimetastatic effects of the third fraction (FR3) from

Indexed as

ApoptosisBauhiniaCaspase 3Cell DeathCell Line, TumorCell MovementCytotoxinsFatty AcidsHeLa CellsHumansHydroxybenzoatesInositolLeukocytes, MononuclearMatrix Metalloproteinase 2Matrix Metalloproteinase 9Neoplasm InvasivenessCASP3 protein, humanCaspase 3CytotoxinsFatty AcidsHydroxybenzoatesInositolMatrix Metalloproteinase 2Matrix Metalloproteinase 9phenolic acidpinitolPlant ExtractsReceptor-Interacting Protein Serine-Threonine KinasesReceptors, Tumor Necrosis Factor, Type I

Identifiers

PMID29770331
PMCPMC5889885
OpenAlexW2792652214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.